This inventor holds 1 USPTO granted patent. Top assignee: Samsung Life Public Welfare Foundation. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: YeonSook Choi: Innovator in Patient-Specific Anti-Cancer Agents
Introduction
YeonSook Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of patient-specific anti-cancer agents. His work reflects a commitment to advancing personalized medicine and improving patient outcomes.
Latest Patents
YeonSook Choi holds a patent for a "Method for screening patient-specific anti-cancer agent using limiting dilution assay." This screening method is designed to select anti-cancer agents that are tailored to individual genetic properties. It utilizes a minimal amount of cancer cells, allowing for precise and rapid selection of effective treatments. This innovative approach is crucial for the development of novel anti-cancer agents and enhances the field of personalized medicine.
Career Highlights
Choi is currently associated with the Samsung Life Public Welfare Foundation, where he continues to focus on research that aims to improve cancer treatment methodologies. His dedication to innovation in healthcare has positioned him as a key figure in the fight against cancer.
Collaborations
Some of his notable coworkers include Do Hyun Nam and Kyeung Min Joo, who contribute to the collaborative efforts in advancing cancer research and treatment.
Conclusion
YeonSook Choi's work exemplifies the intersection of innovation and healthcare, particularly in the realm of personalized cancer treatment. His contributions are paving the way for more effective and individualized therapies, ultimately benefiting patients worldwide.